Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | |
| Sales | 8,984 | 20 |
| Gross Profit | 8,984 | 20 |
| Operating Expenses | 21,064 | 10,510 |
| Operating Income | -12,080 | -10,490 |
| Interest Expense | 597 | 110 |
| Other Income | 311 | 0 |
| Pre-tax Income | -12,366 | -10,600 |
| Net Income Continuous | -12,366 | -10,600 |
| Net Income | $-12,366 | $-10,600 |
| EPS Basic Total Ops | -395.14 | N/A |
| EPS Basic Continuous Ops | -394.98 | N/A |
| EPS Diluted Total Ops | -395.14 | N/A |
| EPS Diluted Continuous Ops | -394.98 | N/A |
| EBITDA(a) | $-8,905 | $-9,390 |